Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Oxitriptan | hsa00030 | Pentose phosphate pathway | 3.33E-03 | 2 | P60891, P37837 | PRPS1, TALDO1 | More | | Oxitriptan | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Oxitriptan | hsa00250 | Alanine, aspartate and glutamate metabolism | 1.22E-02 | 2 | Q96RQ9, P15104 | IL4I1, GLUL | More | | Oxitriptan | hsa00270 | Cysteine and methionine metabolism | 3.39E-02 | 2 | Q96RQ9, P40926 | IL4I1, MDH2 | More | | Oxitriptan | hsa00310 | Lysine degradation | 4.57E-02 | 2 | Q96KQ7, Q02809 | EHMT2, PLOD1 | More | | Oxitriptan | hsa00350 | Tyrosine metabolism | 3.40E-02 | 1 | P28332 | ADH6 | More | | Oxitriptan | hsa00500 | Starch and sucrose metabolism | 1.34E-02 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Oxitriptan | hsa00561 | Glycerolipid metabolism | 1.12E-02 | 3 | Q8NEB5, P14550, Q86XP1 | PPAPDC1B, AKR1A1, DGKH | More | | Oxitriptan | hsa00562 | Inositol phosphate metabolism | 2.00E-02 | 4 | P27987, P19174, P42338, Q02252 | ITPKB, PLCG1, PIK3CB, ALDH6A1 | More | | Oxitriptan | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Oxitriptan | hsa00630 | Glyoxylate and dicarboxylate metabolism | 1.67E-02 | 2 | P40925, P15104 | MDH1, GLUL | More | | Oxitriptan | hsa00730 | Thiamine metabolism | 3.83E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Oxitriptan | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Oxitriptan | hsa00900 | Terpenoid backbone biosynthesis | 1.22E-02 | 2 | P49354, Q9UHG3 | FNTA, PCYOX1 | More | | Oxitriptan | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.12E-02 | 1 | P14868 | DARS | More | | Oxitriptan | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 4.50E-02 | 1 | P28332 | ADH6 | More | | Oxitriptan | hsa00982 | Drug metabolism - cytochrome P450 | 4.50E-02 | 1 | P28332 | ADH6 | More | | Oxitriptan | hsa01230 | Biosynthesis of amino acids | 4.31E-02 | 2 | P60891, P37837 | PRPS1, TALDO1 | More | | Oxitriptan | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | | Oxitriptan | hsa03013 | RNA transport | 3.98E-02 | 9 | P52298, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | | Oxitriptan | hsa03040 | Spliceosome | 1.62E-02 | 8 | Q14562, O43143, O60508, P08579, Q07955, Q01130, Q13243, P11142 | DHX8, DHX15, CDC40, SNRPB2, SFRS1, SFRS2, SFRS5, HSPA8 | More | | Oxitriptan | hsa03450 | Non-homologous end-joining | 4.21E-02 | 1 | P13010 | XRCC5 | More | | Oxitriptan | hsa04012 | ErbB signaling pathway | 2.00E-02 | 4 | P16333, P17252, P19174, P42338 | NCK1, PRKCA, PLCG1, PIK3CB | More | | Oxitriptan | hsa04014 | Ras signaling pathway | 7.71E-04 | 10 | P42338, P20827, P49767, Q13009, P17252, P14921, P0DP23, P62873, P50151, P19174 | PIK3CB, EFNA1, VEGFC, TIAM1, PRKCA, ETS1, CALM1, GNB1, GNG10, PLCG1 | More | | Oxitriptan | hsa04015 | Rap1 signaling pathway | 9.88E-03 | 8 | P20827, P49767, P11215, Q13009, P42338, P0DP23, P17252, P19174 | EFNA1, VEGFC, ITGAM, TIAM1, PIK3CB, CALM1, PRKCA, PLCG1 | More | | Oxitriptan | hsa04020 | Calcium signaling pathway | 3.09E-03 | 11 | P27987, Q96DU7, Q13557, P17252, P21860, O15399, P19174, P0DP23, P26678, P63092, P49767 | ITPKB, ITPKC, CAMK2D, PRKCA, ERBB3, GRIN2D, PLCG1, CALM1, PLN, GNAS, VEGFC | More | | Oxitriptan | hsa04024 | cAMP signaling pathway | 4.34E-02 | 6 | P42338, P0DP23, Q13370, O15399, P25963, Q13009 | PIK3CB, CALM1, PDE3B, GRIN2D, NFKBIA, TIAM1 | More | | Oxitriptan | hsa04062 | Chemokine signaling pathway | 1.25E-02 | 9 | P42338, P19174, P62873, P50151, P43250, Q13009, P14598, P42224, P25963 | PIK3CB, PLCG1, GNB1, GNG10, GRK6, TIAM1, NCF1, STAT1, NFKBIA | More | | Oxitriptan | hsa04070 | Phosphatidylinositol signaling system | 3.29E-03 | 6 | P19174, P0DP23, P42338, P23743, P27987, P17252 | PLCG1, CALM1, PIK3CB, DGKA, ITPKB, PRKCA | More | | Oxitriptan | hsa04071 | Sphingolipid signaling pathway | 1.87E-02 | 6 | Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415 | EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2 | More | | Oxitriptan | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | | Oxitriptan | hsa04146 | Peroxisome | 2.42E-02 | 5 | O43933, P56589, Q9UKG9, O75521, P33121 | PEX1, PEX3, CROT, ECI2, ACSL1 | More | | Oxitriptan | hsa04151 | PI3K-Akt signaling pathway | 1.43E-02 | 12 | P42338, P20827, P49767, P08238, P62873, P50151, P16144, O15335, Q13751, P14784, P01568, P17252 | PIK3CB, EFNA1, VEGFC, HSP90AB1, GNB1, GNG10, ITGB4, CHAD, LAMB3, IL2RB, IFNA21, PRKCA | More | | Oxitriptan | hsa04217 | Necroptosis | 2.97E-03 | 11 | P01375, P01568, P48023, Q13489, P42224, Q14765, P08238, P15104, Q6FI13, Q99878, O43633 | TNF, IFNA21, FASLG, BIRC3, STAT1, STAT4, HSP90AB1, GLUL, H2AC18; H2AC19, H2AC14, CHMP2A | More | | Oxitriptan | hsa04330 | Notch signaling pathway | 1.12E-02 | 3 | Q92542, P49768, P46531 | NCSTN, PSEN1, NOTCH1 | More | | Oxitriptan | hsa04360 | Axon guidance | 2.13E-03 | 7 | P16333, P20827, O95631, P17252, P42338, P23528, P19174 | NCK1, EFNA1, NTN1, PRKCA, PIK3CB, CFL1, PLCG1 | More | | Oxitriptan | hsa04370 | VEGF signaling pathway | 7.68E-03 | 3 | P19174, P42338, P17252 | PLCG1, PIK3CB, PRKCA | More | | Oxitriptan | hsa04510 | Focal adhesion | 7.77E-03 | 9 | P16144, O75369, P42338, Q15942, P17252, O15335, Q13751, Q13489, P49767 | ITGB4, FLNB, PIK3CB, ZYX, PRKCA, CHAD, LAMB3, BIRC3, VEGFC | More | | Oxitriptan | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | | Oxitriptan | hsa04613 | Neutrophil extracellular trap formation | 7.32E-03 | 13 | O60603, P05164, P08246, Q9UM07, Q6FI13, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Oxitriptan | hsa04622 | RIG-I-like receptor signaling pathway | 3.39E-02 | 2 | Q12933, P10145 | TRAF2, IL8 | More | | Oxitriptan | hsa04623 | Cytosolic DNA-sensing pathway | 4.57E-02 | 2 | P01568, P25963 | IFNA21, NFKBIA | More | | Oxitriptan | hsa04650 | Natural killer cell mediated cytotoxicity | 4.40E-02 | 6 | P78314, P06239, O60880, P20963, P26718, O75015 | SH3BP2, LCK, SH2D1A, CD247, KLRK1, FCGR3B | More | | Oxitriptan | hsa04657 | IL-17 signaling pathway | 4.98E-02 | 6 | O00463, Q16539, P14780, Q9UJX4, P80188, P01375 | TRAF5, MAPK14, MMP9, ANAPC5, LCN2, TNF | More | | Oxitriptan | hsa04658 | Th1 and Th2 cell differentiation | 9.73E-03 | 6 | P20963, P09693, Q16539, P06239, Q9UL17, P13765 | CD247, CD3G, MAPK14, LCK, TBX21, HLA-DOB | More | | Oxitriptan | hsa04659 | Th17 cell differentiation | 1.05E-03 | 13 | P25963, Q16539, P19174, P06239, P42224, P14784, P13765, P14778, P40189, Q9UL17, P08238, P09693, P20963 | NFKBIA, MAPK14, PLCG1, LCK, STAT1, IL2RB, HLA-DOB, IL1R1, IL6ST, TBX21, HSP90AB1, CD3G, CD247 | More | | Oxitriptan | hsa04664 | Fc epsilon RI signaling pathway | 2.00E-02 | 4 | P42338, P17252, P19174, P09917 | PIK3CB, PRKCA, PLCG1, ALOX5 | More | | Oxitriptan | hsa04666 | Fc gamma R-mediated phagocytosis | 8.08E-03 | 5 | P42338, P19174, P23528, P14598, P17252 | PIK3CB, PLCG1, CFL1, NCF1, PRKCA | More | | Oxitriptan | hsa04713 | Circadian entrainment | 5.73E-04 | 9 | O15399, P0DP23, Q13557, Q02153, P17252, P62873, P50151, P61952, P63092 | GRIN2D, CALM1, CAMK2D, GUCY1B3, PRKCA, GNB1, GNG10, GNG11, GNAS | More | | Oxitriptan | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Oxitriptan | hsa04724 | Glutamatergic synapse | 8.08E-03 | 5 | O15399, P17252, P62873, P50151, P15104 | GRIN2D, PRKCA, GNB1, GNG10, GLUL | More | | Oxitriptan | hsa04725 | Cholinergic synapse | 4.26E-02 | 4 | P17252, P62873, P50151, P42338 | PRKCA, GNB1, GNG10, PIK3CB | More | | Oxitriptan | hsa04726 | Serotonergic synapse | 2.54E-02 | 5 | P17252, P62873, P50151, P33260, P09917 | PRKCA, GNB1, GNG10, CYP2C18, ALOX5 | More | | Oxitriptan | hsa04727 | GABAergic synapse | 1.23E-02 | 4 | P62873, P50151, P15104, P17252 | GNB1, GNG10, GLUL, PRKCA | More | | Oxitriptan | hsa04728 | Dopaminergic synapse | 2.41E-02 | 5 | P63092, P61952, Q99941, Q13557, O15516 | GNAS, GNG11, CREBL1, CAMK2D, CLOCK | More | | Oxitriptan | hsa04740 | Olfactory transduction | 2.52E-02 | 1 | Q9H255 | OR51E2 | More | | Oxitriptan | hsa04742 | Taste transduction | 1.01E-02 | 1 | P30939 | HTR1F | More | | Oxitriptan | hsa04744 | Phototransduction | 1.67E-02 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Oxitriptan | hsa04911 | Insulin secretion | 4.88E-02 | 3 | P63092, Q99941, Q13557 | GNAS, CREBL1, CAMK2D | More | | Oxitriptan | hsa04914 | Progesterone-mediated oocyte maturation | 1.24E-02 | 5 | P42338, Q13370, Q9UJX4, P30304, P08238 | PIK3CB, PDE3B, ANAPC5, CDC25A, HSP90AB1 | More | | Oxitriptan | hsa04926 | Relaxin signaling pathway | 1.53E-02 | 6 | P25963, P42338, P62873, P50151, P49767, P17252 | NFKBIA, PIK3CB, GNB1, GNG10, VEGFC, PRKCA | More | | Oxitriptan | hsa04932 | Non-alcoholic fatty liver disease | 2.74E-02 | 3 | P01375, P49841, P48023 | TNF, GSK3B, FASLG | More | | Oxitriptan | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.43E-02 | 5 | P42224, P42338, P49767, P17252, P19174 | STAT1, PIK3CB, VEGFC, PRKCA, PLCG1 | More | | Oxitriptan | hsa04934 | Cushing syndrome | 1.75E-02 | 4 | Q99941, P63092, O15169, Q13557 | CREBL1, GNAS, AXIN1, CAMK2D | More | | Oxitriptan | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Oxitriptan | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Oxitriptan | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Oxitriptan | hsa04977 | Vitamin digestion and absorption | 3.43E-02 | 1 | P41440 | SLC19A1 | More | | Oxitriptan | hsa05020 | Prion disease | 3.28E-02 | 2 | Q92736, O60282 | RYR2, KIF5C | More | | Oxitriptan | hsa05031 | Amphetamine addiction | 4.88E-02 | 3 | Q13557, P63092, Q99941 | CAMK2D, GNAS, CREBL1 | More | | Oxitriptan | hsa05032 | Morphine addiction | 1.24E-02 | 5 | P62873, P50151, Q13370, P17252, P43250 | GNB1, GNG10, PDE3B, PRKCA, GRK6 | More | | Oxitriptan | hsa05110 | Vibrio cholerae infection | 3.15E-02 | 3 | Q13488, P17252, P19174 | TCIRG1, PRKCA, PLCG1 | More | | Oxitriptan | hsa05132 | Salmonella infection | 4.83E-02 | 2 | O00471, O60282 | EXOC5, KIF5C | More | | Oxitriptan | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | | Oxitriptan | hsa05143 | African trypanosomiasis | 7.50E-04 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | | Oxitriptan | hsa05144 | Malaria | 1.44E-03 | 6 | P60033, P69905, P68871, O60603, P35443, P26718 | CD81, HBA2, HBB, TLR2, THBS4, KLRK1 | More | | Oxitriptan | hsa05145 | Toxoplasmosis | 3.45E-02 | 6 | P25963, Q13489, P42224, P09917, Q13751, P11142 | NFKBIA, BIRC3, STAT1, ALOX5, LAMB3, HSPA8 | More | | Oxitriptan | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Oxitriptan | hsa05163 | Human cytomegalovirus infection | 1.62E-02 | 8 | P42338, P25963, P62873, P50151, P0DP23, P17252, P30101, P01568 | PIK3CB, NFKBIA, GNB1, GNG10, CALM1, PRKCA, PDIA3, IFNA21 | More | | Oxitriptan | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 4.56E-03 | 9 | P01568, P42224, P25963, P42338, P40189, P62873, P50151, P19174, P0DP23 | IFNA21, STAT1, NFKBIA, PIK3CB, IL6ST, GNB1, GNG10, PLCG1, CALM1 | More | | Oxitriptan | hsa05168 | Herpes simplex virus 1 infection | 6.31E-03 | 13 | P25963, P01568, P42224, Q07955, Q01130, Q13243, Q13489, P30101, P42338, Q13398, Q03923, O75820, Q9UDV6 | NFKBIA, IFNA21, STAT1, SFRS1, SFRS2, SFRS5, BIRC3, PDIA3, PIK3CB, ZNF211, ZNF85, ZNF189, ZNF212 | More | | Oxitriptan | hsa05169 | Epstein-Barr virus infection | 4.41E-02 | 8 | P13765, Q13547, O00463, Q16539, P24522, O60603, P09693, P20963 | HLA-DOB, HDAC1, TRAF5, MAPK14, GADD45A, TLR2, CD3G, CD247 | More | | Oxitriptan | hsa05170 | Human immunodeficiency virus 1 infection | 7.66E-03 | 10 | P42338, P62873, P50151, P0DP23, P17252, P30101, P01568, P25963, P19174, P23528 | PIK3CB, GNB1, GNG10, CALM1, PRKCA, PDIA3, IFNA21, NFKBIA, PLCG1, CFL1 | More | | Oxitriptan | hsa05171 | Coronavirus disease - COVID-19 | 3.30E-02 | 7 | P25963, P42224, P01568, P40189, P42338, P19174, P17252 | NFKBIA, STAT1, IFNA21, IL6ST, PIK3CB, PLCG1, PRKCA | More | | Oxitriptan | hsa05200 | Pathways in cancer | 9.80E-05 | 21 | Q13751, P42338, P08238, P42224, P25963, P19174, P17252, P43246, P10826, P14923, Q13489, P49767, P14921, P62873, P50151, P78417, O75293, P0DP23, P01568, P14784, P40189 | LAMB3, PIK3CB, HSP90AB1, STAT1, NFKBIA, PLCG1, PRKCA, MSH2, RARB, JUP, BIRC3, VEGFC, ETS1, GNB1, GNG10, GSTO1, GADD45B, CALM1, IFNA21, IL2RB, IL6ST | More | | Oxitriptan | hsa05202 | Transcriptional misregulation in cancer | 1.45E-02 | 12 | Q15532, P41732, P14780, P27930, P14923, Q16548, Q13077, O15550, P35226, P05164, P08246, P24522 | SS18, TSPAN7, MMP9, IL1R2, JUP, BCL2A1, TRAF1, UTX, BMI1, MPO, ELA2, GADD45A | More | | Oxitriptan | hsa05214 | Glioma | 2.73E-03 | 5 | P0DP23, P17252, P42338, P19174, O75293 | CALM1, PRKCA, PIK3CB, PLCG1, GADD45B | More | | Oxitriptan | hsa05222 | Small cell lung cancer | 1.10E-02 | 6 | P10826, P42338, Q13751, Q13489, P25963, O75293 | RARB, PIK3CB, LAMB3, BIRC3, NFKBIA, GADD45B | More | | Oxitriptan | hsa05223 | Non-small cell lung cancer | 4.91E-03 | 5 | P17252, P42338, P19174, P10826, O75293 | PRKCA, PIK3CB, PLCG1, RARB, GADD45B | More | | Oxitriptan | hsa05231 | Choline metabolism in cancer | 4.91E-03 | 5 | P42338, Q9Y259, P19174, P23743, P17252 | PIK3CB, CHKB, PLCG1, DGKA, PRKCA | More | | Oxitriptan | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.03E-02 | 5 | P20963, P09693, P06239, O60603, Q16539 | CD247, CD3G, LCK, TLR2, MAPK14 | More | | Oxitriptan | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Oxitriptan | hsa05332 | Graft-versus-host disease | 3.70E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Oxitriptan | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | |